Corporate information

Official name
ViroPharma Incorporated
Registration country

Company type

Provider of life-saving medicines for life-threatening diseases.

Overview

ViroPharma Incorporated is an international biopharmaceutical company committed to developing and commercializing novel solutions for physician specialists to address unmet medical needs of patients living with diseases that have few if any clinical therapeutic options. ViroPharma is developing a portfolio of therapeutics for rare and Orphan diseases including C1 esterase inhibitor deficiency, cytomegalovirus (CMV), Friedreich's Ataxia, eosinophilic esophagitis (EoE) and adrenal insufficiency. ViroPharma's goal is to provide rewarding careers to employees, to create new standards of care in the way serious diseases are treated, and to build international partnerships with the patients, advocates, and health care professionals it serves. ViroPharma's commercial products address diseases including hereditary angioedema (HAE), seizures in children and adolescents, adrenal insufficiency and C. difficile-associated diarrhea (CDAD).



Funding rounds

Acquisition USD 495,000,000


USD 495,000,000 ( ) at USD 495,000,000 pre-money valuation

Profile Country Notes
Abbott Laboratories USD 495,000,000 (USD 495,000,000) Initial investment. Led the round.

Acquisition USD 4,200,000,000


USD 4,200,000,000 ( ) at USD 4,200,000,000 pre-money valuation

Profile Country Notes
Shire PLC USD 4,200,000,000 (USD 4,200,000,000) Initial investment. Led the round.

Profile Country
Ben Franklin Technology Partners of Southeastern Pennsylvania (BFTP/SEP) Initiative of the Pennsylvania Department of Community and Economic Development.

Profile Country
Angelo Gordon & Co LP A privately-held registered investment advisor dedicated to alternative investing

Profile Country
BayStar Capital

Profile Country
Frazier Healthcare Ventures Investment firm providing growth and venture capital to healthcare companies.

Profile Country
Perseus LLC Merchant bank and private equity fund management company.


Investment activity status
Active investor

Current team

Past employees

Selected Products / Customers

Financials